Cefaclor Price Trend and Forecast 2026: Latest Global Market Analysis and Industry Outlook

 

According to ChemAnalyst, the global Cefaclor Price Trend experienced downward pressure across major markets during the second quarter of 2026, as increased export availability and comfortable inventories outweighed higher freight and logistics expenses. In the United States, the Cefaclor Price Index declined by 6.75% quarter-over-quarter, with the average price reaching approximately USD 212,560.67/MT. China recorded a 6.76% decrease, with an average price of around USD 212,423.33/MT, while Germany registered a 6.75% decline to approximately USD 212,557.33/MT. In contrast, India recorded a 4.59% quarter-over-quarter increase, reflecting higher landed costs.

Cefaclor is a semi-synthetic, second-generation cephalosporin antibiotic used to treat bacterial infections. It is commonly prescribed for susceptible respiratory tract, ear, skin, and urinary tract infections. The pharmaceutical ingredient is available in different dosage forms, including capsules, tablets, and oral suspensions.

The Cefaclor Price is influenced by the availability and cost of pharmaceutical intermediates, manufacturing capacity, regulatory compliance, freight rates, and demand from pharmaceutical companies. Since global supply depends significantly on production facilities in Asia, changes in Chinese and Indian export availability can influence prices in importing markets.

Cefaclor Price Trend Across Key Regions

North America

The United States Cefaclor Price Index declined by 6.75% quarter-over-quarter during Q2 2026. The average price stood at approximately USD 212,560.67/MT. Increased availability of Chinese and Indian-origin material placed downward pressure on offers, while subdued seasonal demand reduced purchasing urgency among wholesalers and pharmaceutical buyers.

Despite sharp increases in container freight and insurance expenses, improved import availability outweighed the additional logistics costs. The depreciation of the Chinese yuan also helped ease dollar-denominated export quotations, adding further pressure to landed prices.

Wholesalers maintained inventory buffers of approximately four to five weeks, reducing the need for immediate spot purchases. Hospital tender activity and seasonal procurement remained relatively muted, while buyers focused on drawing down existing stocks. As a result, suppliers faced pressure to offer competitive prices to maintain sales volumes.

The near-term Cefaclor Price Trend in North America will depend on import arrivals, freight expenses, inventory replenishment, and demand from pharmaceutical distributors.

Asia-Pacific

China recorded a 6.76% quarter-over-quarter decline in its Cefaclor Price Index during Q2 2026. The average price was approximately USD 212,423.33/MT. Ample domestic supply, higher coastal inventories, and weaker export enquiries contributed to the decline.

Major Chinese producers continued operating at relatively high capacity utilisation, keeping export-grade material available in the market. Stable coal-derived energy costs and sufficient availability of 7-ADCA feedstock also helped manufacturers maintain production without significant cost increases.

Exporters reduced FOB offers as overseas enquiries weakened and buyers delayed new purchase orders. Domestic volume-based procurement and inventory drawdowns further limited immediate demand. These conditions encouraged sellers to provide price concessions to clear available stocks.

India, however, recorded a 4.59% quarter-over-quarter increase in its Cefaclor Price Index. Higher landed costs supported the market, although spot prices softened in June as state tenders moderated purchasing and private pharmaceutical formulators postponed orders.

The regional market will remain sensitive to Chinese production rates, 7-ADCA availability, export demand, and procurement activity from Indian pharmaceutical manufacturers.

Europe

Germany's Cefaclor Price Index declined by 6.75% quarter-over-quarter in Q2 2026. The average price was approximately USD 212,557.33/MT. Greater availability of Asian exports and competitive supplier quotations placed pressure on the European market.

Shipments from suppliers in Zhejiang, China, and Andhra Pradesh, India, increased market availability. Some exporters reduced quotations to manage port-side inventories, allowing German importers to negotiate more competitive purchasing terms.

Although energy and production expenses remained elevated, their influence on the final product price was limited by the availability of imported material. Weak pharmaceutical procurement and cautious purchasing patterns also restricted the scope for price recovery.

The European Cefaclor Price Trend will continue to depend on Asian export availability, currency movements, freight costs, and purchasing activity among pharmaceutical formulators and distributors.

𝐓𝐫𝐚𝐜𝐤 𝐑𝐞𝐚𝐥 𝐓𝐢𝐦𝐞 𝐏𝐫𝐢𝐜𝐞𝐬 𝐎𝐟 𝐂𝐞𝐟𝐚𝐜𝐥𝐨𝐫

https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Cefaclor

Key Factors Influencing the Cefaclor Price

Several supply-side and demand-side factors influence the global Cefaclor Price. Understanding these variables can help manufacturers, distributors, and procurement teams assess market movements.

1. 7-ADCA Feedstock Availability

7-Aminodeacetoxycephalosporanic acid (7-ADCA) is an important intermediate in cefaclor manufacturing. Its availability and cost influence production economics. Changes in upstream penicillin-based intermediate supply, fermentation operations, and supplier capacity can affect the cost of manufacturing cefaclor.

When 7-ADCA supply becomes limited, manufacturers may face higher procurement expenses. Conversely, stable feedstock availability can help producers maintain output and limit upward price pressure.

2. Pharmaceutical Manufacturing Capacity

Cefaclor production requires specialised manufacturing facilities, quality-control systems, and regulatory compliance. Plant maintenance, production interruptions, and changes in operating rates can influence market availability.

High operating rates among major producers can increase exportable supply and place downward pressure on prices. Unexpected shutdowns or reduced production can tighten availability and support a price recovery.

3. Freight and Logistics Costs

International trade plays an important role in the cefaclor supply chain. Container freight, maritime insurance, port congestion, and transportation expenses affect the landed cost for importers.

During Q2 2026, higher freight and insurance costs provided some support to landed prices in importing regions. However, improved export availability from China and India outweighed these additional expenses in several markets.

4. Pharmaceutical Demand and Procurement

Demand from pharmaceutical formulators, hospitals, wholesalers, and distributors influences purchasing activity. Seasonal prescription patterns, hospital tenders, inventory management, and procurement schedules can cause changes in demand.

During periods of weaker purchasing activity, buyers may rely on existing stocks and delay new orders. This can increase competition among suppliers and place pressure on spot prices.

5. Regulatory and Quality Requirements

Pharmaceutical ingredients must meet applicable quality, purity, and manufacturing standards. Good Manufacturing Practice requirements, product testing, documentation, and regulatory inspections add to production and compliance expenses.

Suppliers operating approved facilities may face higher costs but can benefit from stronger acceptance among regulated pharmaceutical buyers.

Cefaclor Price Forecast 2026

The Cefaclor Price Forecast 2026 will depend on the balance between Asian export supply, pharmaceutical demand, feedstock availability, and international logistics costs.

In China, ample inventories and competitive export offers may continue to limit price increases if production remains stable. However, unexpected plant maintenance, tighter 7-ADCA availability, or stronger overseas enquiries could improve supplier pricing power.

In the United States and Germany, import availability and distributor inventory levels will remain important factors. If wholesalers continue drawing down existing stocks and hospital procurement remains cautious, spot prices may face further pressure. A return to seasonal restocking or an increase in freight expenses could provide some support.

India may experience a different pricing pattern depending on domestic pharmaceutical demand, import costs, and procurement activity from formulation manufacturers. The market's direction will also depend on the availability of competitively priced material from overseas suppliers.

Overall, the Cefaclor Price Trend is likely to remain sensitive to changes in production costs and international trade conditions. Buyers should monitor 7-ADCA feedstock prices, supplier operating rates, export quotations, freight expenses, and distributor inventories before making procurement decisions.

Applications of Cefaclor

Cefaclor is used in pharmaceutical formulations to treat infections caused by susceptible bacteria. Its principal applications include:

• Respiratory tract infections: Used in prescribed treatments for certain cases of bronchitis, pneumonia, and other susceptible bacterial respiratory infections.

• Ear infections: Used for selected bacterial infections, including otitis media.

• Skin and soft-tissue infections: Included in treatments for certain infections caused by susceptible organisms.

• Urinary tract infections: Used in selected cases where the causative bacteria are susceptible to cefaclor.

• Pharmaceutical formulations: Supplied as capsules, tablets, and oral suspensions for different patient requirements.

Cefaclor is a prescription antibiotic. Its use should follow appropriate medical guidance and local treatment guidelines.

Conclusion

The global Cefaclor market recorded downward price movements across the United States, China, and Germany during Q2 2026, while India experienced an increase. Greater Asian export availability, comfortable inventories, and subdued procurement activity were the main factors behind the declines in major importing markets. Higher freight expenses provided some cost support but were insufficient to reverse the overall downward movement.

Looking ahead, the Cefaclor Price Trend will depend on 7-ADCA availability, pharmaceutical manufacturing capacity, export supply, freight costs, and downstream procurement. Monitoring these factors will help buyers and manufacturers understand market developments and plan their purchasing strategies. 

Contact -

Address:
420 Lexington Avenue, Suite 300
New York, NY 10170
United States

Phone: +1 332 258 6602

Website: www.chemanalyst.com

LinkedIn: https://www.linkedin.com/company/chemanalyst/

X (Twitter): https://x.com/chemanalysts

Facebook: https://www.facebook.com/ChemAnalysts/